Demographic and clinical characteristics of allogeneic BMT survivors and siblings
| Variable . | BMT survivors, n = 1554 .  | Siblings, n = 907 .  | P . | 
|---|---|---|---|
| VTE, n (%) | |||
| Yes | 80 (5.15) | 29 (3.20) | .023 | 
| Age at survey, y | |||
| Mean (SD) | 50.51 (15.38) | 54.17 (14.65) | <.0001 | 
| Sex, n (%) | |||
| Male | 830 (53.41) | 361 (39.80) | <.0001 | 
| Race/Ethnicity, n (%) | <.0001 | ||
| White | 1137 (73.17) | 783 (86.33) | |
| Hispanic | 236 (15.19) | 66 (7.28) | |
| Asian | 30 (1.93) | 19 (2.09) | |
| Black | 104 (6.69) | 29 (3.20) | |
| Other | 47 (3.02) | 10 (1.10) | |
| Education, n (%) | .0005 | ||
| ≤High school | 264 (16.99) | 117 (12.90) | |
| Some college | 565 (36.36) | 310 (34.18) | |
| College graduate | 679 (43.69) | 473 (52.15) | |
| Missing | 46 (2.96) | 7 (0.77) | |
| Household income, n (%) | <.0001 | ||
| ≤$50000 | 458 (29.47) | 198 (21.83) | |
| $50000-$100000 | 435 (27.99) | 268 (29.55) | |
| >$100000 | 633 (40.73) | 347 (38.26) | |
| Missing | 28 (1.80) | 94 (10.36) | |
| History of smoking, n (%) | |||
| Ever | 478 (30.76) | 353 (38.92) | <.0001 | 
| Alcohol intake, n (%) | |||
| Yes | 768 (48.42) | 540 (59.54) | <.0001 | 
| Exercise, n (%) | |||
| Yes | 1106 (71.17) | 725 (79.93) | <.0001 | 
| Comorbidities, n (%) | |||
| Diabetes | 228 (15.33) | 38 (4.33) | <.0001 | 
| Hypertension | 448 (33.09) | 187 (22.48) | <.0001 | 
| Dyslipidemia | 411 (30.22) | 155 (18.59) | <.0001 | 
| Chronic kidney disease | 58 (3.77) | 33 (3.65) | .877 | 
| Congestive heart failure | 65 (4.20) | 13 (1.44) | .0002 | 
| Coronary heart disease | 52 (3.35) | 26 (2.87) | .507 | 
| Arrhythmia | 143 (9.43) | 59 (6.58) | .014 | 
| Stroke | 50 (3.22) | 14 (1.55) | .012 | 
| Chronic GVHD | 506 (34.47) | Not applicable | Not applicable | 
| Medications, n (%) | |||
| Oral contraceptive use | 446 (28.70) | 407 (44.87) | <.0001 | 
| Female hormone replacement | 532 (34.23) | 105 (11.58) | <.0001 | 
| Testosterone replacement | 235 (15.12) | 40 (4.41) | <.0001 | 
| Immunosuppressants | 959 (61.71) | 44 (4.85) | <.0001 | 
| Variable . | BMT survivors, n = 1554 .  | Siblings, n = 907 .  | P . | 
|---|---|---|---|
| VTE, n (%) | |||
| Yes | 80 (5.15) | 29 (3.20) | .023 | 
| Age at survey, y | |||
| Mean (SD) | 50.51 (15.38) | 54.17 (14.65) | <.0001 | 
| Sex, n (%) | |||
| Male | 830 (53.41) | 361 (39.80) | <.0001 | 
| Race/Ethnicity, n (%) | <.0001 | ||
| White | 1137 (73.17) | 783 (86.33) | |
| Hispanic | 236 (15.19) | 66 (7.28) | |
| Asian | 30 (1.93) | 19 (2.09) | |
| Black | 104 (6.69) | 29 (3.20) | |
| Other | 47 (3.02) | 10 (1.10) | |
| Education, n (%) | .0005 | ||
| ≤High school | 264 (16.99) | 117 (12.90) | |
| Some college | 565 (36.36) | 310 (34.18) | |
| College graduate | 679 (43.69) | 473 (52.15) | |
| Missing | 46 (2.96) | 7 (0.77) | |
| Household income, n (%) | <.0001 | ||
| ≤$50000 | 458 (29.47) | 198 (21.83) | |
| $50000-$100000 | 435 (27.99) | 268 (29.55) | |
| >$100000 | 633 (40.73) | 347 (38.26) | |
| Missing | 28 (1.80) | 94 (10.36) | |
| History of smoking, n (%) | |||
| Ever | 478 (30.76) | 353 (38.92) | <.0001 | 
| Alcohol intake, n (%) | |||
| Yes | 768 (48.42) | 540 (59.54) | <.0001 | 
| Exercise, n (%) | |||
| Yes | 1106 (71.17) | 725 (79.93) | <.0001 | 
| Comorbidities, n (%) | |||
| Diabetes | 228 (15.33) | 38 (4.33) | <.0001 | 
| Hypertension | 448 (33.09) | 187 (22.48) | <.0001 | 
| Dyslipidemia | 411 (30.22) | 155 (18.59) | <.0001 | 
| Chronic kidney disease | 58 (3.77) | 33 (3.65) | .877 | 
| Congestive heart failure | 65 (4.20) | 13 (1.44) | .0002 | 
| Coronary heart disease | 52 (3.35) | 26 (2.87) | .507 | 
| Arrhythmia | 143 (9.43) | 59 (6.58) | .014 | 
| Stroke | 50 (3.22) | 14 (1.55) | .012 | 
| Chronic GVHD | 506 (34.47) | Not applicable | Not applicable | 
| Medications, n (%) | |||
| Oral contraceptive use | 446 (28.70) | 407 (44.87) | <.0001 | 
| Female hormone replacement | 532 (34.23) | 105 (11.58) | <.0001 | 
| Testosterone replacement | 235 (15.12) | 40 (4.41) | <.0001 | 
| Immunosuppressants | 959 (61.71) | 44 (4.85) | <.0001 |